Table 2.
Anthropometric measurements and laboratory data for all subjects divided by gender.
| Total (n = 152) |
Men (n = 83) |
Women (n = 69) |
P | |
|---|---|---|---|---|
| BMI | 28 ± 4 | 28 ± 4 | 28 ± 5 | NS |
| Waist circumference (cm) | 93 ± 11 | 95 ± 10 | 90 ± 11 | <0.01 |
| Waist ≥ 90/80 cm (men/women), n (%) |
115 (76%) | 61 (74%) | 54 (79%) | NS |
| SBP (mm Hg) | 119 ± 15 | 124 ± 14 | 113 ± 16 | <0.0001 |
| DBP (mm Hg) | 76 ± 13 | 81 ± 11 | 70 ± 13 | <0.0001 |
| Blood glucose (mg/dL) | 91 ± 24 | 93 ± 29 | 89 ± 16 | NS |
| Total-C (mg/dL) | 208 ± 44 | 209 ± 47 | 207 ± 39 | NS |
| HDL-C (mg/dL) | 52 ± 15 | 46 ± 13 | 58 ± 14 | <0.0001 |
| LDL-C (mg/dL) | 128 ± 36 | 131 ± 38 | 126 ± 34 | NS |
| Non-HDL-C (mg/dL) | 154 ± 43 | 158 ± 43 | 148 ± 42 | NS |
| Creatinine (mg/dL) | 0.8 ± 0.2 | 0.9 ± 0.1 | 0.7 ± 0.1 | <0.0001 |
| hsCRP (mg/L) | 2.1 ± 2.2 | 2.2 ± 2.2 | 2.0 ± 2.2 | NS |
| Lp-PLA2 (nmol/mL/min) | 185 ± 48 | 201 ± 49 | 166 ± 38 | <0.0001 |
Values expressed as mean ± SD, except where indicated.
BMI: body mass index; DBP: diastolic blood pressure; HDL-C: high-density lipoprotein cholesterol; hsCRP: high sensitive C-reactive protein; LDL-C: low-density lipoprotein cholesterol; Lp-PLA2: lipoprotein-associated phospholipase A2; NS: not significant; SBP: systolic blood pressure; SD: standard deviation; total-C: total cholesterol.